A.M. Jelliffe - Concepedia

Author

A.M. Jelliffe

Also Known As

( London, A Jelliffe, A M JELLIFFE, A M Jelliffe, A. M. JELLIFFE, A. M. Jelliffe, A.M Jelliffe, A.M. Jelliffe, AM Jelliffe

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

North Middlesex Hospital Middlesex Hospital Mount Vernon Hospital University College London Queen's Medical Centre

About

A.M. Jelliffe is an author at North Middlesex Hospital specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	31	2.2K
2	Health Sciences	8	8	202
3	Engineering	1	1	12
4	Public Health	1	1	13
5	Allergy	1	1	52

A.M. Jelliffe

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
CLASSIFICATION OF NON-HODGKIN'S LYMPHOMAS MichaelH. Bennett, G Farrer-Brown, Kristin Henry, The Lancet Lymphoid NeoplasiaMedicineHistopathologyDiagnosisPathology	1974	559
Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial KM Ardeshna, Peter Smith, AJ Norton, The Lancet Lymphoid NeoplasiaLong-term EffectHealth PolicyMedicineSystemic Treatment	2003	538
REVIEW OF BRITISH NATIONAL LYMPHOMA INVESTIGATION STUDIES OF HODGKIN'S DISEASE AND DEVELOPMENT OF PROGNOSTIC INDEX J. L. Haybittle, M.J. Easterling, MR Bennett, The Lancet Lymphoid NeoplasiaMedicineImmunodeficienciesSurgical PathologyDiagnosis	1985	183
The Prognosis in Hodgkin's Disease A.M. Jelliffe, A D Thomson British Journal of Cancer Autoimmune DiseaseDisease ProgressionImmunologyHistopathologyDiagnosis	1955	100
The prognostic significance of cellular subtypes in nodular sclerosing Hodgkin's disease: An analysis of 271 non-laparotomised cases (BNLI report no. 22) M.H. Bennett, K.A. MacLennan, M.J. Easterling, Clinical Radiology Lymphoid NeoplasiaSurgical PathologyHistopathologyImmunologyPathology	1983	89
Prolonged Survival of a Bone-marrow Graft Resulting in a Blood-group Chimera J. O. W. Beilby, I. S. Cade, A.M. Jelliffe, BMJ Regenerative MedicineTransplantationMarrow TransplantationBlood-group ChimeraBone Marrow Failure	1960	72
Selective peripheral blood eosinophilia associated with survival advantage in Hodgkin's disease (BNLI Report No 31). British National Lymphoma Investigation. B. Vaughan Hudson, DC Linch, Elizabeth Macintyre, Journal of Clinical Pathology ImmunohematologySelective EosinophiliaImmunologyPathologyEosinophilic Disorder	1987	52
THE MANAGEMENT OF PATHOLOGICAL FRACTURE OF THE MAJOR LONG BONES FROM METASTATIC CANCER Rod Bremner, A.M. Jelliffe Journal of Bone and Joint Surgery - British Volume Surgical OncologyLimb ReconstructionFracture DiagnosticsSurgeryOsteoporosis	1958	51
Vinblastine Sulphate in the Treatment of Malignant Disease N. M. Bleehen, A.M. Jelliffe British Journal of Cancer Vinblastine SulphateMedicinePharmacologyPharmacotherapyAnti-cancer Agent	1965	50
British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease – long term results BW Hancock, G. Vaughan Hudson, B. Vaughan Hudson, British Journal of Cancer Lymphoid NeoplasiaAdvanced HodgkinImmunodeficienciesMedicineImmunology	1991	49

Page 1